- Home
- EXAS vs RRC Comparison
EXAS vs RRC Comparison
Compare EXAS & RRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXAS
- RRC
- Stock Information
- Founded
- EXAS 1995
- RRC 1976
- Country
- EXAS United States
- RRC United States
- Employees
- EXAS N/A
- RRC N/A
- Industry
- EXAS Medical Specialities
- RRC Oil & Gas Production
- Sector
- EXAS Health Care
- RRC Energy
- Exchange
- EXAS Nasdaq
- RRC Nasdaq
- Market Cap
- EXAS 9.1B
- RRC 8.5B
- IPO Year
- EXAS N/A
- RRC N/A
- Fundamental
- Price
- EXAS $45.60
- RRC $34.38
- Analyst Decision
- EXAS Strong Buy
- RRC Hold
- Analyst Count
- EXAS 22
- RRC 17
- Target Price
- EXAS $66.43
- RRC $44.06
- AVG Volume (30 Days)
- EXAS 3.9M
- RRC 2.8M
- Earning Date
- EXAS 08-06-2025
- RRC 07-22-2025
- Dividend Yield
- EXAS N/A
- RRC 1.05%
- EPS Growth
- EXAS N/A
- RRC 0.32
- EPS
- EXAS N/A
- RRC 1.98
- Revenue
- EXAS $2,939,949,000.00
- RRC $2,799,229,500.00
- Revenue This Year
- EXAS $14.61
- RRC $31.08
- Revenue Next Year
- EXAS $12.71
- RRC $14.61
- P/E Ratio
- EXAS N/A
- RRC $17.36
- Revenue Growth
- EXAS 12.55
- RRC 19.93
- 52 Week Low
- EXAS $38.81
- RRC $27.55
- 52 Week High
- EXAS $72.83
- RRC $43.50
- Technical
- Relative Strength Index (RSI)
- EXAS 44.47
- RRC 35.82
- Support Level
- EXAS $40.55
- RRC $33.85
- Resistance Level
- EXAS $45.45
- RRC $35.76
- Average True Range (ATR)
- EXAS 2.04
- RRC 0.86
- MACD
- EXAS 0.07
- RRC -0.01
- Stochastic Oscillator
- EXAS 63.10
- RRC 16.06
About EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.
About RRC Range Resources Corporation
Fort Worth-based Range Resources is an independent exploration and production company with that focuses entirely on its operations in the Marcellus Shale in Pennsylvania. At year-end 2024, Range Resources' proven reserves totaled 18.1 trillion cubic feet equivalent, with net production of 2.18 billion cubic feet equivalent per day. Natural gas accounted for 68% of production.